WHO PQ publishes new guidelines on submission requirements for DMPA

Sep 15, 2015 | WHO PQ

The World Health Organization Prequalification of Medicines Programme has recently published a new guidance document on submission requirements for depot medroxyprogesterone acetate (DMPA) products, following the CTD format. These guidelines should be referred to for any manufacturer of the injectable contraceptive seeking to achieve WHO prequalification.

The document is available here, and can also be found on our Resources page along with other important WHO PQ links and publications.